A web of mail-order pharmacies, wholesalers and patient services groups connected to the self-styled largest Pentecostal denomination in the U.S. has been accused of defrauding pharma juggernaut Eli Lilly out of more than $200 million through a multi-year rebate scheme centered on the diabetes treatment Trulicity.